We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDTH:NASDAQTrident Digital Tech Holdings Ltd - American Depository Shares Analysis

Data as of 2026-05-28 - not real-time

$2.43

Latest Price

9/10Risk

Risk Level: High

Executive Summary

TDTH is trading at $2.43, barely above its 20‑day SMA of $1.85 and well below its 200‑day SMA of $13.91, indicating a strong bearish bias. The 14‑day RSI sits near 53, suggesting no immediate oversold condition, while the MACD histogram is modestly positive, hinting at a faint bullish impulse that is unlikely to overcome the prevailing downtrend. Fundamentally, the firm reports zero profit margin, a negative operating margin of –64%, and a price‑to‑sales multiple north of 70, reflecting severe earnings weakness despite a 43.6% revenue growth rate. Volatility is extreme at 182% over 30 days and a beta of 1.63, underscoring price instability. Recent news that TDTH regained Nasdaq’s minimum bid price compliance removes a delisting threat, and the launch of a sovereign‑scale digital tax platform in Ghana could open new growth avenues, yet these catalysts are nascent and unproven.
Overall, the combination of a fragile technical position, distressed fundamentals, and high market risk outweighs the modest upside from compliance restoration and early‑stage expansion, making the stock a high‑risk speculative play.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price just above technical support but below key moving averages
  • Regaining Nasdaq compliance removes immediate delisting risk
  • Extreme short‑term volatility and weak earnings

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential revenue upside from African digital tax platform rollout
  • Continued negative cash flow and high debt relative to cash
  • Bearish technical trend persisting despite slight MACD bullishness

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained negative profitability and deteriorating book value
  • High beta and volatility indicating unstable price performance
  • Uncertain ability to translate growth initiatives into sustainable earnings

Key Metrics & Analysis

Financial Health

Revenue Growth43.60%
ROA-288.03%
P/B Ratio-1.4
Op. Cash Flow$-9716106
Free Cash Flow$-980533
Industry P/E40.4

Technical Analysis

TrendBearish
RSI53.1
Support$1.28
Resistance$2.78
MA 20$1.85
MA 50$3.37
MA 200$13.91
MACDBullish
VolumeIncreasing
Fear & Greed Index92.34

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.63
Volatility182.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.